Page last updated: 2024-08-21

triphenyltetrazolium and coomassie brilliant blue

triphenyltetrazolium has been researched along with coomassie brilliant blue in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arbeloa, J; Gottlieb, M; Matute, C; Pérez-Samartín, A1

Other Studies

1 other study(ies) available for triphenyltetrazolium and coomassie brilliant blue

ArticleYear
P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia.
    Neurobiology of disease, 2012, Volume: 45, Issue:3

    Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Brain Injuries; Calcium; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Excitatory Amino Acid Agonists; Fluoresceins; Glucose; Hypoxia; In Vitro Techniques; Infarction, Middle Cerebral Artery; Membrane Potentials; N-Methylaspartate; Neurologic Examination; Neurons; Organic Chemicals; Patch-Clamp Techniques; Phosphopyruvate Hydratase; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Tetrazolium Salts

2012